Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/TRYP-THERAPEUTICS-INC-116833711/news/Tryp-Therapeutics-gibt-Zwischenergebnisse-der-klinischen-Phase-II-Studie-zur-Behandlung-von-Binge-Ea-42672834/?utm_source=whatsapp&utm_medium=social&utm_campaign=share